Photo of Lara Davis taken from OHSU Knight Cancer Institute/Facebook
Nov 7, 2023, 02:56
Lara Davis: A bench to clinic to bench to clinic story in Ewing sarcoma
Lara Davis, OHSU Knight Cancer Institute Sarcoma Program Director, shared on Twitter:
“A bench to clinic to bench to clinic story in Ewing sarcoma.
CTOS2023, TRABECTEDIN AS A 1-HOUR INFUSION IN COMBO WITH LOW DOSE IRINOTECAN.
Knowing the Ewing’s PK threshold informed study design – and when hit, EWS-FLI1 transcriptome reverses!”
Source: Lara Davis/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 15:33
Nov 21, 2024, 15:20
Nov 21, 2024, 14:56
Nov 21, 2024, 14:41
Nov 21, 2024, 13:55
Nov 21, 2024, 13:46
Nov 21, 2024, 13:25